Dose‐dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin
Clinical and Translational Science · 2024-08 · 17 (8)
DOI: 10.1111/cts.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 16.08.2024. Verfasst von Nicolas Hohmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Pharmacoepidemiology, Internal Medicine IX, Medical Faculty of Heidelberg, Heidelberg University Hospital, Un…. Hauptthemen laut MEDLINE: Rifampin, Hypericum, Midazolam, Cytochrome P-450 CYP3A. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The dose dependence of the effect of enzyme inducers and the effect of the combined administration of two inducers that exert their effect via the same induction pathway (pregnane X receptor) have not been well studied. Using oral midazolam microdoses (30 μg), we have investigated CYP3A4 induction by St. John's wort (SJW) in 11 healthy volunteers using low (300 mg/day containing 7.48 mg hyperforin), therapeutic (900 mg/day), and supratherapeutic doses of SJW (1800 mg/day) for 14 days. SJW was then co‐administered with rifampin (600 mg/day) for a further 7 days to evaluate the effect of the combined administration of two inducers. In addition, intravenous midazolam microdoses (10 μg) were administered before SJW, at SJW 1800 mg/day, and during administration of the two inducers to assess the hepatic contribution to total induction (semi‐simultaneous administration). Administration of SJW increased oral midazolam clearance 1.96‐fold (300 mg/day), 3.86‐fold (900 mg/day), and 5.62‐fold (1800 mg/day), and 17.5‐fold after the addition of rifampin. Concurrently, the clearance of intravenous midazolam increased 2.05‐fold (1800 mg/day) and 2.93‐fold (SJW + rifampin). These results show that rifampin significantly enhances the induction of the highest SJW doses both hepatically and overall and suggest that these metabolic effects occur predominantly in the gut. These findings also suggest that in drug interactions involving strong and moderate enzyme inducers, the perpetrator effects of the strong inducer are decisive for the interaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Pharmacoepidemiology, Internal Medicine IX, Medical Faculty of Heidelberg, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.
ORCID-Profile: Nicolas Hohmann, Jürgen Burhenne, Antje Blank, Gerd Mikus, Walter E Haefeli
Zitieren
APA
Hohmann, N., Friedrichs, A. S., Burhenne, J., Blank, A., Mikus, G., & Haefeli, W. E. (2024). Dose‐dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin. Clinical and Translational Science, 17(8). https://doi.org/10.1111/cts.70007
Vancouver
Hohmann N, Friedrichs AS, Burhenne J, Blank A, Mikus G, Haefeli WE. Dose‐dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin. Clinical and Translational Science. 2024;17(8). doi:10.1111/cts.70007
BibTeX
@article{Hohmann2024,
author = {Hohmann, Nicolas and Friedrichs, Anna S and Burhenne, Jürgen and Blank, Antje and Mikus, Gerd and Haefeli, Walter E},
title = {Dose‐dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin},
journal = {Clinical and Translational Science},
year = {2024},
volume = {17},
number = {8},
doi = {10.1111/cts.70007}
}
EUVIMED